Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Oct;68(10):5991-7.
doi: 10.1128/IAI.68.10.5991-5997.2000.

Trehalose 6,6'-dimycolate (cord factor) of Mycobacterium tuberculosis induces corneal angiogenesis in rats

N Saita  1 , N Fujiwara, I Yano, K Soejima, K Kobayashi
Affiliations

Trehalose 6,6'-dimycolate (cord factor) of Mycobacterium tuberculosis induces corneal angiogenesis in rats

N Saita et al. Infect Immun. 2000 Oct.

Abstract

Neovascularization or angiogenesis is required for the progression of chronic inflammation. The mechanism of inflammatory neovascularization in tuberculosis remains unknown. Trehalose 6, 6'-dimycolate (TDM) purified from Mycobacterium tuberculosis was injected into rat corneas. TDM challenge provoked a local granulomatous response in association with neovascularization. Neovascularization was seen within a few days after the challenge, with the extent of neovascularization being dose dependent, although granulomatous lesions developed 14 days after the challenge. Cytokines, including tumor necrosis factor alpha (TNF-alpha), interleukin-8 (IL-8), IL-1beta, and vascular endothelial growth factor (VEGF), were found in lesions at the early stage (within a few days after the challenge) and were detectable until day 21. Neovascularization was inhibited substantially by neutralizing antibodies to VEGF and IL-8 but not IL-1beta. Treatment with anti-TNF-alpha antibodies resulted in partial inhibition. TDM possesses pleiotropic activities, and the cytokine network plays an important role in the process of neovascularization.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Induction of corneal neovascularization in rats by TDM challenge. Corneas challenged with vehicle alone did not develop neovascularization. TDM challenge induced corneal neovascularization by day 3 that persisted up to day 21 in a dose-dependent fashion. Arrowheads indicate new blood vessels in the cornea.
FIG. 2
FIG. 2
Time kinetic study of corneal neovascularization induced by TDM challenge. New vessel growth is expressed as the maximal lengths and widths of new vessels. Data are means ± SD (n = 10/group). The asterisks indicate statistical significance relative to results with control (CTRL) rats challenged with vehicle alone (P < 0.02).
FIG. 3
FIG. 3
Histopathology of rat corneas challenged with TDM. Histologic sections (4 μm thick) of formalin-fixed, paraffin-embedded tissues were stained with hematoxylin and eosin. Polymorphonuclear leukocytes infiltrated primarily at the site of TDM challenge until day 3. Focal accumulation of macrophages, including epithelioid macrophages, was evident by day 14, suggesting the development of granulomas. Neovascularization was found around granulomas but not in the center of the lesion (indicated by arrows). In the immunohistochemical analysis, the new blood vessels were positive for factor VIII-related antigen, a specific marker for endothelial cells (arrows).
FIG. 4
FIG. 4
Antigenic cytokine levels in corneas challenged with TDM. Local cytokine levels were measured with commercially available EIA kits. Data are means ± SD (n = 10/group). The asterisks indicate statistical significance relative to values for control rats challenged with vehicle alone (∗, P < 0.0001; ∗∗, P < 0.001; ∗∗∗, P < 0.05; ∗∗∗∗, P < 0.001).
FIG. 5
FIG. 5
Inhibition of TDM-induced corneal neovascularization by in vivo treatment with neutralizing anti-cytokine antibodies (Ab) to IL-1β, TNF-α, IL-8, and VEGF. Administration of antibodies to IL-8 and VEGF substantially inhibited neovascularization, although antibodies to IL-1β and TNF-α did not induce significant inhibition. Antibodies were injected into the sites indicated by arrowheads. The pictures represent lesions 6 days after the treatment.
FIG. 6
FIG. 6
Morphometric analyses of the inhibition of TDM-induced corneal neovascularization by in vivo treatment with neutralizing anti-cytokine antibody (Ab). Data are means ± SD (n = 10/group). The asterisks indicate statistical significance relative to values for control (CTRL) rats challenged with vehicle alone (∗, P < 0.01; ∗∗, P < 0.05).
See this image and copyright information in PMC

References

    1. Amano S, Rohan R, Kuroki M, Tolentino M, Adamis A P. Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization. Investig Ophthalmol Vis Sci. 1998;39:18–22. - PubMed
    1. Asano M, Nakane A, Minagawa T. Endogenous gamma interferon is essential in granuloma formation induced by glycolipid-containing mycolic acid in mice. Infect Immun. 1993;61:2872–2878. - PMC - PubMed
    1. Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu Rev Immunol. 1997;15:675–705. - PubMed
    1. Bekierkunst A, Yarkoni E. Granulomatous hypersensitivity to trehalose-6,6′-dimycolate (cord factor) in mice infected with BCG. Infect Immun. 1973;7:631–638. - PMC - PubMed
    1. Besra G S, Chatterjee D. Lipids and carbohydrates of Mycobacterium tuberculosis. In: Bloom B R, editor. Tuberculosis: pathogenesis, protection, and control. Washington, D.C.: ASM Press; 1994. pp. 285–306.

Publication types

LinkOut - more resources